Medical Marijuana, Inc. Announces $14 Million Debt Reduction and Major Strategic Acquisitions in the Fourth Quarter of 2015


Medical Marijuana, Inc. Eliminates Approximately $14 Million in Long-Term Debt and Extends Maturities on Remaining Debt Obligations and Acquires and Consolidates Into Its Operations 93.4% of HempMeds® Brasil™, Remaining 20% of HempMeds® PX Not Already Owned; 100% Each of HempMeds® Puerto Rico™ and HempMeds® Mexico™

SAN DIEGO, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (the “Company”) (OTC Pink:MJNA) is pleased to announce the Company has significantly reduced its debt obligation from $24 million at the close of the third quarter (ending 9/30/2015) to approximately $10 million at the close of the fourth quarter (ending 12/31/2015), a reduction of approximately $14 million. The Company also acquired and consolidated several of its partnerships including 93.4% of HempMeds® Brasil™, LLC and the remaining 20% of HempMeds® PX that Medical Marijuana, Inc. did not already own from affiliated parties that comprise the largest shareholder of the Company.

Prior to the acquisitions, the Company sold its RSHO™ products to HempMeds Brasil™ and the other consolidated companies at wholesale, which then in turn sold those products retail to consumers in their respective markets. As a result of the acquisitions, the Company will now realize the full margin between the cost of manufacturing the product and retail pricing on the sales of the product.

The acquisition of the remaining 20% of HempMeds® PX was completed after HempMeds® PX acquired HempMeds® PR (Puerto Rico) Ventures, LLC and KannaMex™, LLC from the same affiliated shareholder. The combined purchase price for the two acquisitions was $13,875,000. Under the terms of the acquisitions, the purchase price is subject to downward adjustment if the aggregate post-acquisition valuation of both entities (as of the transaction date of December 31, 2015) by a recognized independent valuation firm is less than the purchase price and is not subject to upward adjustment unless the aggregate valuation is greater than $100 million (as of December 31, 2015) and such upward valuation is nonetheless subject to a cap of $20 million.

The acquisition by HempMeds® PX of HempMeds® Puerto Rico™ and KannaMex™ was completed immediately prior to the Company’s acquisition of HempMeds® PX for the nominal sum of $100,000. The value of these two entities shall not be included in the aggregate valuations of HempMeds® Brasil™ and HempMeds® PX unless their aggregate valuation is less than the purchase price.

In commenting on the transactions, CEO Stuart Titus stated: “The elimination of $14 million in debt and associated improvement in our balance sheet combined with the acquisitions enhances the Company’s positioning for significant growth. We believe that we’re acquiring 93.4% of HempMeds Brasil™ and the 20% of our flagship U.S.-based operation HempMeds® PX for a fraction of what the independent valuations will show these entities to be worth. In the very unlikely event that we’re wrong, the transaction structure protects the shareholders through a purchase price reduction. I’m most excited by the fact that we’ve completed the acquisitions when Brazil has barely begun to realize what we believe to be the potential for explosive growth. Our products have been approved by the Brazilian government as a prescription by Brazilian doctors to patients suffering from Epilepsy, Parkinson’s and Chronic Pain. These represent enormous markets in Brazil with these conditions estimated to affect approximately 20 million people.”

Titus went on to say, “In addition, HempMeds® Puerto Rico and KannaMex™ were essentially included in the deal for what amounts to mere nominal consideration. Puerto Rico holds great potential, specifically the Company has 12 medical product registrations as well as an agreement for the distribution and marketing of those products by the island’s largest private pharmaceutical sales and distribution company. KannaMex™ made significant inroads in Mexico and we expect to announce some of those accomplishments in the very near future. We believe that Mexico alone has the potential to be as large or even larger than the South American markets we have already been approved in. Our affiliated largest shareholders that entered into these transactions at these prices, and with these protections for the shareholders, have demonstrated an impressive commitment to enhancing shareholder value for itself, and for the other shareholders of the Company. I could not be more optimistic about what this means for our future.”

Summary of above:

Loan Payable Chicago Ventures:

(a) Amount outstanding reduced from $8,299,189 (as of 9/30/2015) to approximately $5.09 million (as of 12/31/2015), a reduction of approximately $3.2 million.

(b) The note still has $2 million in cash, available to be drawn down upon included in the $5.09 million balance.

(c) Extended the maturity date of the note from February 17, 2016, to October 17, 2017.

HDDC Notes Payable:

(a) Reduced HDDC notes payable from $13,980,338 (as of 9/30/15) to approximately $2.96 million of notes payable (as of 12/31/2015), a reduction of approximately $11 million. Extended maturity on the remaining note payable from January 2017 to January 2026.

Below is a summary of the acquisitions and related acquisitions:

(a) The company acquired the 20% balance of HempMeds® PX following HempMeds® PX having acquired 100% of HempMeds® Puerto Rico™ and 100% of HempMeds® Mexico™. As a result the Company now owns 100% of HempMeds® PX and 100% each of HempMeds® Puerto Rico™ and HempMeds® Mexico™ by virtue of its ownership of HempMeds® PX. The Company acquired 93.4 percent of HempMeds® Brasil™.

About Medical Marijuana Inc.
The mission of Medical Marijuana, Inc. (OTC Pink:MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value.

For more information, please visit the company's website at:

About HempMeds® Brasil
HempMeds Brasil™ currently has three cannabis products approved for importation into Brazil as a prescription medication for Epilepsy, Parkinson's and Chronic Pain. The company had the first-ever cannabis product allowed for import into Brazil and its products are currently subsidized by the Brazilian government, under their health care system, for all three medical indications listed above. HempMeds Brasil™ is working on additional approvals for multiple indications.

For more information, please the company’s website at:

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

         For further information, please contact:
         Public Relations contact:
         Andrew Hard
         Chief Executive Officer
         CMW Media
         P. 888-829-0070
         Corporate Contact:
         Medical Marijuana, Inc.
         Toll Free: 888-OTC-MJNA (888-682-6562)


One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700

NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra NASDAQ OMX

Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra NASDAQ OMX

BroadSoft Hospitality Enhanced with Mobile UC-One Workstream Collaboration Capabilities to Amplify Productivity and Guest Experiences23.10.2017 07:30Pressemelding

New BroadSoft Hospitality features integrated into UC-One Connect allow hotels to access, respond to and act on guest requests in real-time, no matter where they are on the property PHOENIX, Oct. 23, 2017 (GLOBE NEWSWIRE) -- BroadSoft, Inc. (NASDAQ:BSFT), a global market share leader in cloud business software for unified communication as a service (UCaaS), and provider of collaboration and contact center as a service (CCaaS), today announced new UC-One mobile features for the BroadSoft Hospitality solution. The new features provide hotels with the ability to control the guest experience at any time from the UC-One mobile client. A photo accompanying this announcement is available at This new offering is a continuation of ongoing efforts by BroadSoft to help hotels deliver a greater level of experience to their guests. The mobile integration allows front desk hotel

BroadSoft Announces New Integrated and Intelligent Cloud Communication and Collaboration Experiences23.10.2017 07:30Pressemelding

Upgrades deliver on the BroadSoft Business cloud unified communication vision to deliver intuitive, consistent client experiences across the entire suite and reinvent workflow efficiencies PHOENIX, Oct.  23, 2017  (GLOBE NEWSWIRE) -- BroadSoft, Inc. (NASDAQ:BSFT) a global market share leader in cloud business software for unified communication as a service (UCaaS), and provider of collaboration and contact center as a service (CCaaS), today unveiled several enhancements to its BroadSoft Business portfolio at its annual user conference, BroadSoft Connections. Now leveraging a microservices architecture, BroadSoft Business offers updated app experiences and next-generation capabilities across the BroadSoft Business applications, UC-One, Team-One and CC-One. A photo accompanying this announcement is available at Business users today are overwhelmed with managing their workfl

Powered by BroadSoft Channel Program Introduces New Digital Customer Lifecycle Platform and Services to Enhance Revenue Growth23.10.2017 07:30Pressemelding

Powered by BroadSoft now includes more than 100 global channel partners to realize the full potential of the cloud unified communication and collaboration market opportunity PHOENIX, Oct.  23, 2017  (GLOBE NEWSWIRE) -- BroadSoft, Inc. (NASDAQ:BSFT) a global market share leader in cloud business software for unified communication as a service (UCaaS), and provider of collaboration and contact center as a service (CCaaS) today announced the addition of new digital customer lifecycle management tools including the BroadCloud® Channel Support System (CSS) and three new services: BroadSoft go-to-market services, BroadSoft onboarding services and BroadSoft adoption services. A photo accompanying this announcement is available at   Powered by BroadSoft, which launched at BroadSoft Connections last year, currently supports 116 channel partners across the globe, v

BroadSoft Business Cloud PBX, Team Collaboration and Contact Center Apps Now Available for Multinational Enterprises23.10.2017 07:30Pressemelding

New, localized data centers offer multinational enterprise customers secure, multi-language calling and collaboration between global offices via a single, borderless BroadCloud platform PHOENIX, Oct.  23, 2017  (GLOBE NEWSWIRE) -- BroadSoft, Inc. (NASDAQ:BSFT) a global market share leader in cloud business software for unified communication as a service (UCaaS), and provider of collaboration and contact center as a service (CCaaS), today announced its BroadSoft Business cloud communication suite is available worldwide via several new BroadCloud ® data centers throughout EMEA and APAC. This expansion allows multinational enterprises to rely on a single provider across their international locations to collaborate with peers and customers around the globe, while meeting full regulatory and security compliance across different countries. A recent McKinsey Global Institute 2016 report noted that cross-border bandwidth is projected to increase nine times over the next

Cappasity Starts ARToken crowdsale and Adds Cryptocurrency Expert David Drake to its Advisory Board23.10.2017 06:45Pressemelding

SANTA CLARA, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Cappasity, a company that develops a platform and an AR/VR blockchain ecosystem for 3D content production and mass distribution, is announcing the start of a crowdsale of ARToken (AR) on October 25, at 1 PM UTC. David Drake, Chairman at LDJ Capital, joins Cappasity's advisory board to provide counsel on critical issues relating to the specifics of the ICO process, blockchain and investor relations. A photo accompanying this announcement is available at Today, Cappasity is announcing the start of the crowdsale of ARToken - a new digital currency that will be used as the primary payment unit within the global decentralized AR/VR Ecosystem for 3D content exchange. As a token sale is a very important step for the development of the company's project, Cappasity has decided to consult the deep expertise of one o

H.B. Fuller Poised for Global Growth with Acquisition of Royal Adhesives & Sealants23.10.2017 02:00Pressemelding

ST. PAUL, Minn., Oct. 22, 2017 (GLOBE NEWSWIRE) -- Boosting H.B. Fuller's (NYSE:FUL) problem-solving potential, the company today announces it has finalized its acquisition of Royal Adhesives & Sealants for $1.575 billion. Few people realize the impact of adhesives. They are everywhere, making virtually any durable or consumer product better. Adhesives have the potential to make the world a better place, and H.B. Fuller is tapping adhesives in unique ways to improve a range of global issues. H.B. Fuller, combined with Royal, deepens its expertise in specialty and high-value applications used in a range of sectors, including electronics, hygiene, medical, transportation, clean energy, construction, and more. Together, the companies will enable an interconnected world, support better use of the world's finite resources, improve food security and access to clean drinking water, and address the challenges of a globally disperse and aging population. "This is an exciting step

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom